Navigation Links
Duska Therapeutics Sponsored University of Pennsylvania Study Demonstrates ATP Improves Sperm Motility and In Vitro Fertilization in Animals
Date:5/14/2008

LA JOLLA, Calif., May 14 /PRNewswire-FirstCall/ -- Duska Therapeutics, Inc. (OTC Bulletin Board: DSKA.OB) ("Duska" or the "Company") announced today that scientists from the University of Pennsylvania's Center for Research on Reproduction and Women's Health have published the results of the Company's sponsored study showing that extracellular ATP (adenosine 5'-triphosphate) improves sperm motility and increases fertilizing capability in mice.

The data was published online in the journal Biology of Reproduction (http://www.biolreprod.org/cgi/content/abstract/biolreprod.107.065565).

The University of Pennsylvania scientists studied sperm obtained from two mouse strains: one with normal and the other one with low fertilization capacity. Extracellular ATP treatment of these sperm in vitro (outside of the body) resulted in improved sperm motility parameters and was associated with a rapid increase in the level of intracellular calcium. The effect was inhibited by two P2 receptor antagonists. Furthermore, extracellular ATP treatment of mouse sperm resulted in increased success rates of in vitro fertilization (IVF) procedures. The improved fertilization rate was much more pronounced when sperm from the mouse strain with low fertility were used.

The authors suggest that ATP's activation of P2 receptors to modulate sperm function may be beneficial for artificial reproductive techniques.

"We are extremely pleased with the positive results of sperm treatment with ATP, which were obtained in this second Duska-sponsored study," said Dr. Amir Pelleg, Duska's President and Chief Scientific Officer. "These results indicate that the mechanism of action of extracellular ATP on improving sperm motility and fertilization potency is mediated by P2 receptors and increased level of intracellular calcium. The data further support the development of ATPotent(TM
'/>"/>

SOURCE Duska Therapeutics
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Duska Therapeutics Plans 505(b)(2) NDA Filing Route for ATPace(TM)
2. Transition Therapeutics to Hold Conference Call on Third Quarter Fiscal 2008 Financial Results on Wednesday, May 14, 2008 at 4:30 P.M. EST
3. TorreyPines Therapeutics Reports First Quarter 2008 Financial Results and Accomplishments
4. Jane Moffitt, J.D., LL.M. Named Vice President of Regulatory Affairs of Nile Therapeutics
5. Zevalin Revenues Lead Cell Therapeutics, Inc.s First Quarter 2008 Financial Results
6. Nektar Therapeutics Announces First Quarter 2008 Results
7. TorreyPines Therapeutics Licenses Intellectual Property from Johns Hopkins Related to Novel Uses of Glutamate Receptor Antagonists for Prevention, Treatment of Stroke, Heart Attack
8. Transition Therapeutics to Present at 2008 Morgan Stanley Global Healthcare Unplugged Conference
9. Echo Therapeutics and Cato BioVentures Sign Right of First Offer Agreement for Dermatology Products and Transdermal Drug Delivery Technologies
10. CV Therapeutics to Announce 2008 First Quarter Financial Results on Friday, April 25, 2008
11. Precision Therapeutics Adds 8 Million Covered Lives Under Contract
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/8/2015)... ... July 08, 2015 , ... LaunchPoint, a provider of ... Gold-Level Fit-Friendly Worksite by the American Heart Association for the second year in ... and stay active through its Swellness Program, which promotes, “It’s swell to be ...
(Date:7/8/2015)... ... July 08, 2015 , ... Health & Disability ... on July 29th in Bettendorf, IA. This workshop will be presented to community-based ... members, veterans, and their families. Professionals from both civilian and military organizations are ...
(Date:7/8/2015)... ... 08, 2015 , ... Garden Retreat Spa , located in the heart ... NYC. The attractive masseuses that staff Garden Retreat Spa specialize in offering table showers, ... With plenty of parking, and a location just a few blocks from Penn Station, ...
(Date:7/7/2015)... ... 08, 2015 , ... The National Association of Professional Women (NAPW) ... the Year Circle. She is recognized with this prestigious distinction for leadership in pharmacy. ... 700,000 members and over 200 operating Local Chapters. , “I’m pleased to recognize Alyssa ...
(Date:7/7/2015)... ... July 07, 2015 , ... World Patent Marketing, a ... a medical invention that prevents IV lines from getting entangled. , "The ... be worth $133 billion by 2016," says Scott Cooper, CEO and Creative Director ...
Breaking Medicine News(10 mins):Health News:LaunchPoint Recognized with Second Consecutive American Heart Association Fit-Friendly Worksite Award 2Health News:Health & Disability Advocates to Host Military Sexual Trauma Workshop for Behavioral Health Practitioners and Victim Advocates 2Health News:Garden Retreat Spa Celebrates 8 Years Serving NYC 2Health News:National Association of Professional Women Inducts Dr. Alyssa Greedy, Pharm. D., Pharmacy Manager at Walgreens, Into its VIP Woman of the Year Circle 2Health News:New Evidence Shows Why Hospital Weekend Effect Is So Dangerous As World Patent Marketing Introduces A New Medical Invention 2Health News:New Evidence Shows Why Hospital Weekend Effect Is So Dangerous As World Patent Marketing Introduces A New Medical Invention 3Health News:New Evidence Shows Why Hospital Weekend Effect Is So Dangerous As World Patent Marketing Introduces A New Medical Invention 4Health News:New Evidence Shows Why Hospital Weekend Effect Is So Dangerous As World Patent Marketing Introduces A New Medical Invention 5
... August 2010 - The authors of a new ... strategies for reducing cocaine self-administration in animals that ... humans. Glutamate is the primary ... implicated in drug addiction. Metabotropic glutamate receptors (mGluRs) ...
... Rheumatology today announced the release of revised classification ... Against Rheumatism) for rheumatoid arthritis, which will allow ... earlier stages of the diseasebefore joint damage occursultimately ... is a chronic disease that causes pain, stiffness, ...
... , MONDAY, Aug. 9 (HealthDay News) -- Many stroke ... patients are never prescribed recommended medications in the first ... found that 25 percent of stroke patients stopped taking ... three months after their stroke. "Providers should spend ...
... national health care organizations are more likely to undergo ... of insurance, according to a study appearing in an ... Society Nephrology (JASN). The results may provide insights ... they go on dialysis. For patients whose kidneys ...
... NY, August 9, 2010Without hands-on access to doctors and hospitals, ... on telemedicine "visits" with physicians and specialists on land, a ... Telemedicine and e-Health , a peer-reviewed journal published by Mary ... free online at www.liebertpub.com/tmj Work on an ...
... After more than a decade of development at the National ... mosquito-borne dengue virus has begun human clinical testing. The vaccine ... and Infectious Diseases (NIAID) and is undergoing clinical study at ... About 2.5 billion people in more than 100 countries ...
Cached Medicine News:Health News:Drugs to treat cocaine abuse? 2Health News:New way of classifying rheumatoid arthritis aimed at identifying the disease earlier 2Health News:New way of classifying rheumatoid arthritis aimed at identifying the disease earlier 3Health News:Many Stroke Patients Stop Taking Meds, Study Shows 2Health News:Many Stroke Patients Stop Taking Meds, Study Shows 3Health News:Many Stroke Patients Stop Taking Meds, Study Shows 4Health News:Not all kidney patients treated equal: Differences in care for patients beginning on dialysis 2Health News:Not all kidney patients treated equal: Differences in care for patients beginning on dialysis 3Health News:Human clinical trial of NIH-developed dengue vaccine begins 2Health News:Human clinical trial of NIH-developed dengue vaccine begins 3
(Date:7/7/2015)... , July 7, 2015 Noting the need ... pricing policies currently practiced by the rapidly consolidating pharmacy ... (SCPC) today praised Ohio Governor ... a new state effort to help pull back the ... "We applaud Governor Kasich for bringing badly-needed ...
(Date:7/7/2015)... Biobanks - How to Discover Trends, R&D ... ,Are you interested in the future of medical ... predictions from 2015. You stay ahead for data, benefiting ... results, opportunities and revenue forecasts. That new ... for biobanking and associated technology to improve healthcare ...
(Date:7/7/2015)... Pennsylvania , 7. Juli 2015 ... und -Technik für klinische Studien, gab heute bekannt, ... ein führendes Unternehmen bei Gewinnung und Erhalt von ... die Tochtergesellschaften MediciGlobal , Ltd. und Access ... auch einen Dienst zum Auffinden von Patienten, ...
Breaking Medicine Technology:National LTC Pharmacy Leader Praises Kasich Effort to Bring Transparency to PBM Drug Pricing 2National LTC Pharmacy Leader Praises Kasich Effort to Bring Transparency to PBM Drug Pricing 3Biobanking for Medicine: Technology, Industry and Market 2015-2025 2Biobanking for Medicine: Technology, Industry and Market 2015-2025 3Biobanking for Medicine: Technology, Industry and Market 2015-2025 4Biobanking for Medicine: Technology, Industry and Market 2015-2025 5Biobanking for Medicine: Technology, Industry and Market 2015-2025 6Biobanking for Medicine: Technology, Industry and Market 2015-2025 7Biobanking for Medicine: Technology, Industry and Market 2015-2025 8Biobanking for Medicine: Technology, Industry and Market 2015-2025 9Biobanking for Medicine: Technology, Industry and Market 2015-2025 10BioClinica übernimmt MediciGroup 2BioClinica übernimmt MediciGroup 3BioClinica übernimmt MediciGroup 4
... 2011 Nationally-acclaimed researcher and award-winning author Dr. Cynthia ... National Conference on Cancer Nursing Research that silver treated ... were supposed to prevent. After testing ... with silver coated or silver impregnated fluid pathway components, ...
... Pharmaceuticals, Inc. (Nasdaq: OPTR ) today announced the ... shares of its common stock, offered at a price to ... Optimer from this offering are expected to be $67.5 million, ... offering expenses payable by Optimer.  The offering is expected to ...
Cached Medicine Technology:Instead of Preventing Infections, Silver Coated Needleless IV Connectors May Actually Cause Them, a Nationally-Recognized Expert Tells National Conference on Cancer Nursing Research 2Optimer Pharmaceuticals, Inc. Prices Public Offering of Common Stock 2Optimer Pharmaceuticals, Inc. Prices Public Offering of Common Stock 3
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: